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ABSTRACT
Introduction. A potential non-pharmacologic way to reduce post-
operative pain and bleeding is using an abdominal binder during 
postoperative recovery. This study aims to determine the effect an 
elastic abdominal binder has on postoperative pain and hemorrhage 
after cesarean delivery.  
Methods.  A randomized, single-site, pilot trial was conducted at two 
prenatal care clinics and an academic hospital in Kansas. Beginning 
in April 2013, 60 patients were enrolled if delivering via cesarean. 
Participants were randomized to receive an abdominal binder or to a 
control group (did not use binder). Pain levels were reported by ques-
tionnaire one day after surgery using a 0 to 10 scale, with 10 being the 
worst pain. Patient characteristics and blood loss were assessed by 
medical record review.
Results. Of the 56 patients completing the study, 29 (51.8%) were 
randomized to the binder group and 27 (48.2%) were randomized 
to the control group. The binder group reported significantly lower 
pain score (p = 0.019) and average pain score (p = 0.024). There was 
no difference in body mass index, age, previous surgery, infant birth 
weight, estimated blood loss, and average dose of pain medication 
during the first 24 hours after the cesarean delivery between the two 
groups. There was no difference in pre- and post-operative hemoglo-
bin levels by treatment group (p = 0.406).
Conclusions. Abdominal binders may be associated with improved 
postoperative pain scores but did not affect postoperative hemor-
rhage.  Kans J Med 2018;11(2):48-53.
INTRODUCTION
Postpartum hemorrhage after cesarean delivery is defined as a 
blood loss of greater than 1000 milliliters, a decline in hematocrit 
levels of 10%, or symptoms from blood loss necessitating a blood 
transfusion.1-3 Primary obstetrical hemorrhages occur within the first 
24 hours following delivery and are estimated to occur in 1 to 6% of 
all deliveries.1,4,5 Postpartum hemorrhage continues to be the leading 
cause of maternal mortality worldwide and one of the top three causes 
of maternal death in the United States.1,5,6  Hemorrhage that neces-
sitates transfusion can lead to multiple infectious and non-infectious 
health problems.7 Therefore, the avoidance of transfusion due to 
blood loss after surgery is ideal. 
Postpartum patients delivering by cesarean are a unique subset 
of postoperative patients with specific risks and needs. Cesarean 
patients are in a unique situation in that they must care for a newborn 
infant immediately following surgery. Postoperative pain can affect 
the ability to sleep and lead to frequent nighttime awakenings, which 
can affect daytime functioning and maternal-infant interactions.8,9 
Women with greater pain are less likely to breastfeed. Although nar-
cotics play an important role in postoperative pain control, there 
are potentially serious adverse reactions to these types of medica-
tions, such as opioid-related respiratory depression,10 sedation, and 
pruritus.11 Long-term use of narcotics may lead to gastrointestinal 
dysfunction like constipation and ileus/bowel complications.12 In 
addition, postpartum patients need to ambulate early to reduce the 
risk of thrombosis.10
A potential non-pharmacologic way to reduce postoperative pain 
and diminish postpartum bleeding is with the use of an abdominal 
binder during postoperative recovery.13 The binder is a soft elastic 
band, which attaches around the abdomen and adjusts to different 
abdominal circumferences by overlapping and attaching with Velcro. 
One theory regarding pain control is that an abdominal binder pro-
vides sufficient circumferential compression to reduce stress on the 
wound during transfers and ambulation. Another theory is that the 
binder provides sensory input when in contact with the skin, and that 
the sensory signals override the neural pathways carrying pain signals 
to the brain to some extent. The hemorrhage-prevention theory is 
that the mild pressure from the binder will assist the uterus to remain 
contracted as it begins the process of involution and provide mild tam-
ponade of blood vessels in the wound.
Few randomized controlled studies reporting postoperative out-
comes compared to a control group were found regarding use of 
abdominal binder after cesarean delivery. Cheifetz et al.13 conducted a 
study which demonstrated the benefit of abdominal binders, in which 
patients who wore binders after major abdominal surgery reported 
unchanged pain and postoperative distress. Two randomized studies 
reported conflicting outcomes regarding use of abdominal binders for 
managing postoperative pain and blood loss after cesarean delivery. 
Gillier et al.14 found no significant difference in pain between their two 
study groups on postoperative day one, although a slight, non-signif-
icant difference was noted postoperative day two. In contrast, Ghana 
et al.15 found patients receiving abdominal binders reported less post-
operative pain and less blood loss. Our randomized controlled trial 
aimed to evaluate the effect of abdominal binder use on postoperative 
pain and hemorrhage among patients undergoing cesarean delivery. 
We hypothesized that patients in the intervention group will report 
less postpartum pain, less volume of estimated blood loss, and less 
pain interfering with daily activities postpartum. 
METHODS
This was a randomized controlled, single-site, pilot trial. The 
study was conducted at a teaching hospital in Wichita, Kansas with 
a goal of enrolling sixty patients over one year. The patients were 
recruited consecutively from two local clinics; one clinic was a private 
clinic and the other was a clinic staffed by resident physicians. This 
study was approved by two local institutional review boards and
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Women receiving prenatal care at either of the two clinics and 
planned to deliver via cesarean were eligible to participate in the study. 
Additional inclusion criteria included cesarean delivery at term (at 
least 39 weeks gestation) scheduled in advance, singleton gestation 
confirmed by ultrasound in the current pregnancy, aged 18 - 39 years 
old, were able to read and understand spoken English, and had a body 
mass index of 20kg/m2 to 40 kg/m2 pre-pregnancy or at the first pre-
natal visit. 
Exclusion criteria included bleeding disorder or use of antico-
agulants, methadone usage, abnormal placenta (placenta previa or 
placenta accreta), preoperative hemoglobin less than 10mg/dL, or cho-
rioamnionitis (intrauterine infection). Patients that had chronic pain 
syndrome, defined as participating in formal chronic pain management 
within the past year, were excluded from the study. Two investigators 
reviewed each patient’s eligibility, and obtained informed consent from 
the patient to participate in the study. A patient was excluded from the 
study if onset of labor occurred prior to the time when the cesarean 
was scheduled, or if the following complications developed during the 
cesarean: placental abnormality (placenta accreta, increta, or percreta), 
vasa previa, cesarean hysterectomy due to severe hemorrhage, or organ 
damage (cystotomy, enterotomy, ureteral injury). 
After obtaining informed consent, one-to-one randomization was 
used to assign 30 women to the intervention and 30 women to the com-
parison group. A sample size of 30 per group was considered adequate 
for a pre-testing/feasibility study of such an intervention.16,17 In regard 
to pain outcomes, the study was powered adequately for a reasonable 
improvement in pain scores. The following estimate was drawn from 
published results of the instrument for measuring the primary outcome 
for improving pain control, the Brief Pain Inventory-Short Form, in 
postoperative patients.18-20 For the question about pain experienced 
“on average,” the studies found pain scores of approximately 4 on the 
instrument’s 0 - 10 scale, with a standard deviation of approximately 
2. If the binder was associated with a drop in average pain score of 
1.5 points on the scale, (i.e., a score of 2.5 in the intervention group 
versus 4.0 in the control group), there would be a statistically signifi-
cant result with 30 participants per group using an alpha of .05 and 
power of 80%.17 Research assistants generated the allocation sequence 
and randomization size, which were concealed to clinical investigators 
until interventions were assigned. Investigators enrolled eligible par-
ticipants into the study, and research assistants assigned subjects to 
their respective groups. Random numbers were generated by computer 
in standard fashion and assigned by the research staff using IBM SPSS, 
Version 20, SPSS, Inc. (Chicago, IL). 
Participants assigned to the intervention group received an elastic 
abdominal binder immediately postoperative and were instructed to 
wear the binder for the first 24 hours postoperatively. The women 
assigned to the control group received usual postoperative care, 
but agreed to data collection procedures associated with the study. 
In addition, the control group participants’ physicians were allowed to 
prescribe a binder postoperatively if they believed one was indicated 
or upon patient request. Women in both study groups received pain 
medication as per the orders of their physicians. 
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A medical record review included the collection of the obstetrical 
information and reason for cesarean delivery. These variables include 
basic descriptive information about the pregnancy and delivery, such as 
the reason that the cesarean was scheduled in advance and the mother’s 
age. Medications and dosages administered to the patient within the 
24-hour postoperative period were collected and postoperative bleed-
ing and pain outcomes were recorded.
Each participant completed a questionnaire at 24 hours postop-
eratively (Appendix A). The one-page questionnaire briefly addressed 
bleeding and pain control. Pain was assessed using the Brief Pain 
Inventory-Short Form.21-23 On the questionnaire, the Brief Pain Inven-
tory-Short Form was represented by items 3 - 8 with the exception of 
item 8d which was analyzed separately. Because patients normally do 
not perform work for pay or household work during the postoperative 
period, other investigators studying postoperative pain have deleted 
the item on pain interference with work from the Brief Pain Inventory-
Short Form.22 Instead, investigators modified the work interference 
item to capture a key aspect of the work of being a new mother, feeding 
the baby.
Postoperative blood loss was calculated as the difference between 
documented pre-operative hemoglobin concentration and postopera-
tive hemoglobin concentration (lowest documented concentration 
during the hospital stay). Participants also were provided a bedside log 
to document pad use during the first 24 hours postoperative.
The primary outcome was postoperative pain, which was assessed 
using the Brief Pain Inventory-Short Form. The Brief Pain Inventory-
Short Form is a widely-used instrument which has good psychometric 
properties in assessing pain in surgical patients.21-23 The secondary 
outcome measure was postoperative blood loss by changes in hemo-
globin concentration (difference between pre-operative hemoglobin 
concentration and lowest hemoglobin concentration documented 
postoperative). The number of pads used for vaginal bleeding and dis-
charge during the postoperative period was tracked using a bedside log, 
which was completed by the participant.
Statistical Analysis
Data were analyzed using IBM SPSS, Version 20, SPSS, Inc. 
(Chicago, IL). Key continuous variables included number of pads used 
and the Brief Pain Inventory-Short Form subscale scores for pain 
severity and pain interference with function. Results for the interven-
tion group versus the control group were compared using paired t-tests 
if the data were normally distributed and with Mann-Whitney tests 
if the data were skewed. Proportions were compared using Pearson’s 
Chi-square or by Fisher’s Exact tests when expected values in any cell 
were less than five. All statistical analyses were two-sided. P-value of 
less than 0.05 was considered statistically significant. An intention to 
treat analysis was conducted. Participants were analyzed in the group 
to which they were randomized.
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RESULTS
There were 60 participants consented and randomized to either 
the control group or the intervention group (binder group). Of the 56 
participants completing the study, 29 (51.8%) were randomized to the 
binder group and 27 (48.2%) were randomized to the control group. 
Four participants were excluded after randomization (Figure 1). Two 
participants crossed over to the binder group: one participant request-
ed use of a binder and one participant was given a binder by medical 
staff. An intent-to-treat analysis was performed on 56 patients.
Demographics and clinical characteristics for participants com-
pleting the study are presented in Table 1. Indication for cesarean for 
most participants was previous cesarean (n = 50 of 56, 89.3%). Almost 
all participants received an epidural (n = 55, 98.2%). There was no 
difference in body mass index (BMI), age, previous surgery, infant 
birth weight, estimated blood loss, and average dose of pain medica-
tion during the first 24 hours after the cesarean delivery between the 
two groups. No statistically significant difference in the average dose 
of pain medication was found. There was also no difference in type of 
regional anesthesia used.
Figure 1. Flow diagram of participant randomization into trial. 
Table 1. Patient demographics and clinical characteristicsa.
Characteristic Binder
(n = 29)
Control
(n = 27)
P value
Age at cesarean (years) 28.5 ± 4.7 27.7 ± 4.4 0.420
Number of previous 
vaginal births, median 
(interquartile)
0 (0 - 0) 0 (0 - 0) 0.236
Number of previous 
cesarean deliveries, 
median (interquartile)
1 (0 - 2) 1 (1- 2) 0.354
Body mass index 
calculated during 1st visit
28.9 ± 6.6 28.6 ± 6.3 0.913
Gestational age at 
cesarean (weeks)
39.1 ± 0.3 39.3 ± 0.6 0.094
Infant birth weight 
(grams)
3632.5 ± 449.2 3525.2 ± 514.8 0.346
Reason for cesarean 
delivery
1.000
   Previous 
   cesarean   
   delivery 
26 (89.7%) 24 (88.9%)
   Breech 
   presentation
3 (10.3%) 3 (11.1%)
Received Epidural 28 (96.6%) 27 (100%) 1.000
Received Duramorph 29 (100%) 27 (100%) 1.000
Average Dose of Pain Medication (in milligrams) within the first 24 
hours
   Hydromorphone 
   hydrochloride (IV)
1 ± 0.71 0.92 ± 0.66 1.0000b
   Morphine (IV) 6.11 ± 2.79 6.77 ± 3.95 0.5418
   Nalbuphine   
   hydrochloride
7.5 ± 2.67 11.43 ± 4.76 0.1054b
   Acetaminophen/
   hydrocodone
19.71 ± 10.39 17.42 ± 9.8 0.4783
   Ibuprofen 888.89 ± 266.67 900 ± 282.84 1.0000b
   Oxycodonec 22.5 ± 24.75 18.33 ± 18.93
   Oxycodone   
   and acetaminophend
11.67 ± 7.64 10 ± 0
   Ketorolac  
   tromethamine
86.54 ± 17.65 86.79 ± 17.01 0.9584
Estimated blood loss (cc) 655.17 ± 183.39 668.52 ± 150.73 0.570
Number of pads used 
during 24 hours 
postoperative
5.29 ± 2.27 5.48 ± 1.95 0.381
aAll values in Table 1 were presented as mean ± SD, interquartile range, or as the 
N (%) depending on the characteristics of the variable.
bP-value was calculated based on non-parametric Wilcoxon rank sum test due 
to small sample size. 
cNo p-value can be calculated due to only 3 patients in the binder group and 2 
patients in the control group received Oxycodone.
dNo p-value can be calculated due to only 3 patients in the binder group and 3 
patients in the control group received Percocet.  
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lower pain scores than participants in the control group. The average 
score of participants who responded “lowest level of pain felt postop-
eratively” was 1.66 ± 1.47 for the binder group and 2.56 ± 1.22 for the 
control group (p = 0.019; Figure 2). The binder group also reported 
significantly lower “average pain” scores, 3.45 ± 1.74 compared to 4.48 
± 1.60 for the control group (p = 0.024, Figure 2). “Worst level of pain” 
and “pain right now” also were lower among women receiving the 
binder treatment; however, results were not statistically significant. 
There was not a statistically significant difference in pain interference 
with activities like walking (Table 2). Pain interference with feeding 
the baby was lower among participants receiving the binder, with 
results nearing statistical significance (p = 0.078).
There was no difference in pre-operative to post-operative hemo-
globin levels by treatment group, but participants in the binder group 
had a smaller change in hemoglobin levels preoperative to postopera-
tive (p = 0.406; Figure 3). Binder group participants reported using 
5.29 ± 2.27 pads compared to 5.48 ± 1.95 pads for the control group 
participants, but results were not statistically significant (p = 0.381). 
One patient in the control group received a transfusion.
In regards to adverse events or side effects in each group, two par-
ticipants receiving the binder indicated that wearing the device for 
an extended period caused itching. There were no other side effects 
reported in either group.
Figure 2. Average pain scores for lowest level of pain, average level of pain, 
worst level of pain, and pain at the time of assessment (24 hours postopera-
tively) as indicated by the control group (green) and the intervention group 
(blue).
*Larger value represents worse self-reported pain 24 hours after Cesarean. 
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Table 2. Postoperative pain assessment questions. 
How Much Has Pain Inter-
fered with Your:
Binder
(n = 29)
Control
(n = 27)
Both
(n = 56)
P 
value
General Activity 
(missing = 2)
5.1 ± 3.1 4.9 ± 2.4 5.0 ± 2.7 0.767
Mood 2.0 ± 2.5 3.1 ± 2.8 2.5 ± 2.7 0.122
Walking Ability 
(missing = 4)
4.8 ± 3.2 4.6 ± 3.1 4.7 ± 3.1 0.747
Bonding with your Baby 
(missing = 1)
0.7 ± 1.3 1.7 ± 2.8 1.2 ± 2.2 0.295
Feeding your Baby 
(missing = 2)
0.7 ± 1.2 2.0 ± 2.8 1.3 ± 2.2 0.078
Relationships with other 
People (missing = 1)
0.9 ± 1.8 1.0 ± 2.2 1.0 ± 2.0 0.992
Sleep 3.7 ± 3.3 3.7 ± 2.5 3.7 ± 2.9 0.791
Enjoyment of Life 2.1 ± 2.7 1.9 ± 2.5 2.0 ± 2.6 0.959
*All values were presented as mean ± SD.
Pain was assessed using a visual analog scale, with 0 representing “Does not 
interfere” and 10 representing “Completely interferes.” 
Figure 3. Average hemoglobin levels preoperative compared to postoperative 
levels, and number of pads used based on randomization group.
DISCUSSION
In this study, the use of an elastic abdominal binder significantly 
lowered average postoperative pain scores when compared to the 
control group. However, differences in hemoglobin concentrations 
before and after surgery were not statistically significant. There is 
also no significant difference in the number of pads used between the 
two groups. 
Our results demonstrated that postoperative pain was improved 
with the abdominal binder. To account for the postoperative pain 
medication effect, the average dose of pain medication was compared 
between the intervention and control group. Our findings supported 
previous findings that an abdominal binder reduces postoperative 
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pain among patients going through major abdominal surgery,13 and in 
regard to postoperative pain, our results were in agreement with the 
Ghana et al. study.15
Karlstrom et al.9 reported that 78% of women in their study expe-
rienced pain greater than or equal to 4 on the Visual Analog Scale 
(VAS) during the first 24 hours after cesarean. Since pain may inter-
fere with recovery and impede maternal-infant interactions, results 
suggested that an abdominal binder may alleviate patient pain during 
the first 24 hours following surgery. In our study, average pain report-
ed 24 hours postoperatively among the binder group, was similar to 
the results found by Ghana et al.15 In comparison, the patients in the 
control group in our study had lower average pain compared to their 
study control group. On postoperative day one, Gillier et al.14 reported 
no difference in VAS scores regarding postoperative pain, but noted 
a slight difference in scores postoperative day two. However, in both 
instances, the abdominal binder group reported lower scores for both 
days, which was supported by our results that postoperative pain is 
lower among the abdominal binder group.
Our study found that, in general, pain did not interfere with mater-
nal daily functions or activities postoperative regardless of treatment 
group. However, our study found that with the abdominal binder 
group, women reported lower pain interference when feeding and 
bonding with the baby. Although postoperative pain may not prevent a 
mother from feeding or bonding with the baby, women in greater pain 
are less likely to breastfeed.8,9 Even though our study did not look at 
breastfeeding outcomes explicitly, it demonstrated abdominal binders 
may reduce pain so mothers can feed and bond with their newborns. 
Pain interfering with general activity and walking was slightly higher 
among binder patients, which is in contrast to findings by Cheifetz 
and colleagues that binders may improve mobility.13 However, our 
patients reported pain interfering with general activity and walking 
in the 24-hour postoperative time, whereas Cheifetz’s significant find-
ings are reported on postoperative day five. Additionally, our patients 
may have reported pain interference that may be due to the actual 
compression and bulkiness of the abdominal binder, not the post-
operative pain. Pain interference with postpartum activities should 
be investigated further, especially if binders improve breastfeeding 
initiation and mobility.
Change in hemoglobin concentrations and pad counts were not 
significantly different between the groups, suggesting that the binder 
did not have a significant effect on 24-hour postoperative blood loss. 
This was not surprising, since most blood loss in a cesarean is intra-
operatively. Ghana et al.15 found a statistically significant higher blood 
loss volume in their control group between baseline and 36 hours. 
Similarly, based on results from our study, the difference in hemo-
globin concentration levels before and 24 hours after surgery were 
lower among women in the binder group, although not statistically 
significant. Furthermore, Ghana et al.15 used a method presented by 
Shook et al.24 to calculate blood loss based on estimated patient blood 
volume, and hematocrit levels measured preoperative and postop-
erative. We are unable to extrapolate on the postoperative blood loss 
using the pad counts, since estimated blood loss was not determined 
from the pads; however, we think pad use provides insight regard-
ing blood loss in the postoperative period. Both our study and the 
Ghana et al. study provided estimates of postoperative blood loss, 
which should be investigated in future studies. Overall, there may be a 
possible benefit to binder use and postoperative blood loss at a longer 
duration postoperative, and this should be investigated further from a 
large sample size population.
The findings of this trial are generalizable to the population of preg-
nant women undergoing cesarean delivery; however, caution must be 
taken when interpreting the effectiveness of the abdominal binder. 
One limitation of this prospective randomized controlled trial was 
a smaller sample size and potential reporting bias due to inability to 
blind patients. Because of the small sample, we were unable to detect 
statistical significance between the control and intervention group on 
some important secondary outcomes, such as number of pads used 
during the first 24 hours postoperatively. Our study did not standard-
ize or validate the level of pad saturation, we simply assumed that 
women changed their pad as necessary without determining the exact 
quantity of blood in the pad. Although the same type of pad utilized 
by our institution was used by all study participants, a future study 
may consider using a more accurate measure of postoperative blood 
loss, such as a measuring saturated pads or a menstrual pictogram. 
Additionally, postoperative hemoglobin concentration may have been 
reported in the electronic medical record at varying times, so we are 
unable to report an exact time for the postoperative hemoglobin con-
centration.
In addition to strengths commonly associated with randomized 
controlled trials, a strength of this study was limited loss of follow-up. 
A future study should aim to increase sample size, should consider 
utilizing validated qualitative measurements and estimations of post-
operative blood loss, and determine pain medications used between 
treatment groups.
In conclusion, this study showed significantly improved lowest-
reported pain scores and average pain scores among participants 
randomized to the treatment group (using the binder). Thus, the use 
of an abdominal binder may be a cost-effective, non-pharmacologic 
intervention to reduce postoperative pain after cesarean delivery.
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